This post may contain affiliate links which may compensate us based on your interaction. Please read the disclosures for more information.
Where do the most patients have access to GLP-1 meds — and which states are struggling to keep up?
GLP-1 receptor agonists, medications originally developed for managing type 2 diabetes, have rapidly emerged as highly effective treatment options for obesity. Medications such as semaglutide (branded as Ozempic and Wegovy) work by mimicking a natural hormone that regulates both appetite and blood sugar. These drugs have been shown to facilitate significant weight loss…